Sex Effect in the Decision to Perform Invasive Coronary Angiography in Patients With Chronic Coronary Syndrome After Undergoing Vasodilator Stress MRI.
chronic coronary syndromes
sex differences
stress cardiovascular magnetic resonance
use of invasive coronary angiography
Journal
Journal of magnetic resonance imaging : JMRI
ISSN: 1522-2586
Titre abrégé: J Magn Reson Imaging
Pays: United States
ID NLM: 9105850
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
revised:
05
03
2022
received:
20
12
2021
accepted:
08
03
2022
pubmed:
29
3
2022
medline:
15
11
2022
entrez:
28
3
2022
Statut:
ppublish
Résumé
Stress cardiac MRI permits comprehensive evaluation of patients with known or suspected chronic coronary syndromes (CCS). The impact of sex on the use of invasive cardiac angiography (ICA) after vasodilator stress cardiac MRI is unclear. To evaluate the impact of sex on ICA use after vasodilator stress cardiac MRI. Retrospective. A total of 6229 consecutive patients (age [mean ± standard deviation] 65.2 ± 11.5 years, 38.1% women). A 5-T; a steady-state free-precession cine sequence; stress first-pass perfusion imaging; late enhancement imaging. Patients underwent vasodilator stress cardiac MRI for known or suspected CCS. The ischemic burden (at stress first-pass perfusion imaging) was computed (17-segment model). Multivariate logistic regression was used to evaluate the potential differential association between ischemic burden and use of cardiac MRI-related ICA across sex. A total of 1109 (17.8%) patients were referred to ICA, among which there were significantly more men (762, 19.7%) than women (347, 14.6%). Overall, after multivariate adjustment, female sex was not associated with lower use of ICA (odds ratio [OR] = 0.99; confidence interval [CI] 95%: 0.84-1.18, P = 0.934). However, significant sex differences were detected across ischemic burden. Whereas women with nonischemic vasodilator stress cardiac MRI (0 ischemic segments) were less commonly submitted to ICA (OR = 0.49; CI 95%: 0.35-0.69) in patients with ischemia (>1 ischemic segment), adjusted use of ICA was more frequent in women than men (OR = 1.27; CI 95%: 1.1-1.5). In patients with known or suspected CCS submitted to undergo vasodilator stress cardiac MRI, cardiac MRI-related ICA may be overused in men without ischemia. Furthermore, ICA referral in patients with negative ischemia resulted in greater odds of revascularization in men. 3 TECHNICAL EFFICACY: Stage 5.
Sections du résumé
BACKGROUND
Stress cardiac MRI permits comprehensive evaluation of patients with known or suspected chronic coronary syndromes (CCS). The impact of sex on the use of invasive cardiac angiography (ICA) after vasodilator stress cardiac MRI is unclear.
PURPOSE
To evaluate the impact of sex on ICA use after vasodilator stress cardiac MRI.
STUDY TYPE
Retrospective.
POPULATION
A total of 6229 consecutive patients (age [mean ± standard deviation] 65.2 ± 11.5 years, 38.1% women).
FIELD STRENGTH/SEQUENCE
A 5-T; a steady-state free-precession cine sequence; stress first-pass perfusion imaging; late enhancement imaging.
ASSESSMENT
Patients underwent vasodilator stress cardiac MRI for known or suspected CCS. The ischemic burden (at stress first-pass perfusion imaging) was computed (17-segment model).
STATISTICAL TESTS
Multivariate logistic regression was used to evaluate the potential differential association between ischemic burden and use of cardiac MRI-related ICA across sex.
RESULTS
A total of 1109 (17.8%) patients were referred to ICA, among which there were significantly more men (762, 19.7%) than women (347, 14.6%). Overall, after multivariate adjustment, female sex was not associated with lower use of ICA (odds ratio [OR] = 0.99; confidence interval [CI] 95%: 0.84-1.18, P = 0.934). However, significant sex differences were detected across ischemic burden. Whereas women with nonischemic vasodilator stress cardiac MRI (0 ischemic segments) were less commonly submitted to ICA (OR = 0.49; CI 95%: 0.35-0.69) in patients with ischemia (>1 ischemic segment), adjusted use of ICA was more frequent in women than men (OR = 1.27; CI 95%: 1.1-1.5).
DATA CONCLUSIONS
In patients with known or suspected CCS submitted to undergo vasodilator stress cardiac MRI, cardiac MRI-related ICA may be overused in men without ischemia. Furthermore, ICA referral in patients with negative ischemia resulted in greater odds of revascularization in men.
EVIDENCE LEVEL
3 TECHNICAL EFFICACY: Stage 5.
Substances chimiques
Vasodilator Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1680-1690Informations de copyright
© 2022 International Society for Magnetic Resonance in Medicine.
Références
Kwong RY, Ge Y, Steel K, et al. Cardiac magnetic resonance stress perfusion imaging for evaluation of patients with chest pain. J Am Coll Cardiol 2019;74:1741-1755.
Marcos-Garces V, Gavara J, Monmeneu JV, et al. Vasodilator stress CMR and all-cause mortality in stable ischemic heart disease: A large retrospective registry. JACC Cardiovasc Imaging 2020;13:1674-1686.
Bodi V, Husser O, Sanchis J, Núñez J, et al. Prognostic implications of dipyridamole cardiac MR imaging: A prospective multicenter registry. Radiology 2012;262:91-100.
Bodi V, Sanchis J, Lopez-Lereu MP, et al. Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance based on the ischaemic cascade. Heart 2009;95:49-55.
Bodi V, Sanchis J, Lopez-Lereu MP, et al. Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol 2007;50:1174-1179.
Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020;41:407-477.
Prescott E, Ballo H, Bax JJ, et al. Impact of a decreasing pre-test probability on the performance of diagnostic tests for coronary artery disease. Eur Heart J Cardiovasc Imaging 2019;20:1198-1207.
Crea F, Battipaglia I, Andreotti F. Sex differences in mechanisms, presentation and management of ischaemic heart disease. Atherosclerosis 2015;241:157-168.
Magliano CADS, Monteiro AL, Tura BR, Oliveira CSR, Rebelo ARO, Pereira CCA. Patient and physician preferences for attributes of coronary revascularization. Patient Prefer Adherence 2018;12:757-764.
Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging Committee of the Council on clinical cardiology of the American Heart Association. Circulation 2002;105:539-542.
Kim ES, Carrigan TP, Menon V. Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion. J Am Coll Cardiol 2008;52:672-673.
Daly C, Clemens F, Lopez Sendon JL, et al. Gender differences in the management and clinical outcome of stable angina. Circulation 2006;113:490-498.
Reynolds HR, Shaw LJ, Min JK, et al. Association of sex with Severity of coronary artery disease, ischemia, and symptom burden in patients with moderate or severe ischemia: Secondary analysis of the ISCHEMIA randomized clinical trial [published online ahead of print, 2020 mar 30]. JAMA Cardiol 2020;5(7):773-786.
Acharjee S, Teo KK, Jacobs AK, et al. Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the clinical outcomes utilizing revascularization and aggressive druG evaluation (COURAGE) trial. Am Heart J 2016;173:108-117.
EUGenMed Cardiovascular Clinical Study Group, Regitz-Zagrosek V, Oertelt-Prigione S, et al. Gender in cardiovascular diseases: Impact on clinical manifestations, management, and outcomes. Eur Heart J 2016;37:24-34.
Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics-2007 update: A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 2007;115:e69-e171.
Piepoli MF, Hoes AW, Agewall S, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: The sixth joint task force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & rehabilitation (EACPR). Eur Heart J 2016;37:2315-2381.
Aggarwal NR, Patel HN, Mehta LS, et al. Sex differences in ischemic heart disease: Advances, obstacles, and next steps. Circ Cardiovasc Qual Outcomes 2018;11:e004437.
Marcos-Garces V, Gavara J, Monmeneu JV, et al. A novel clinical and stress cardiac magnetic resonance (C-CMR-10) score to predict long-term all-cause mortality in patients with known or suspected chronic coronary syndrome. J Clin Med 2020;9:1957.
Sharaf B, Wood T, Shaw L, et al. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: Findings from the National Heart, Lung, and Blood Institute-sponsored Women's ischemia syndrome evaluation (WISE) angiographic core laboratory. Am Heart J 2013;166:134-141.
Taqueti VR, Shaw LJ, Cook NR, et al. Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease. Circulation 2017;135:566-577.
Jespersen L, Hvelplund A, Abildstrøm SZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 2012;33:734-744.
Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with non-obstructive coronary artery disease: A report from the Women's ischemia syndrome evaluation study and the St James women take heart project. Arch Intern Med. 2009;169(9):843-850.
Jahnke C, Furundzija V, Gebker R, et al. Sex-based prognostic value of pharmacological cardiac magnetic resonance stress testing: Head-to-head comparison of adenosine perfusion and dobutamine wall motion imaging. Int J Cardiovasc Imaging 2012;28:1087-1098.
Shaw LJ, Merz CN, Pepine CJ, et al. For the Women's ischemia syndrome evaluation (WISE) investigators. The economic burden of angina in women with suspected ischemic heart disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's ischemia syndrome evaluation. Circulation 2006;114:894-904.
Task Force Members, Montalescot G, Sechtem U, et al. ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;2013(34):2949-3003.
Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med 2010;362:886-895.
Greenwood JP, Ripley DP, Berry C, et al. Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: The CE-MARC 2 randomized clinical trial. JAMA 2016;316:1051-1060.
Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-1516.
Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010;56:177-184.
Bucciarelli-Ducci C, Ostenfeld E, Baldassarre LA, et al. Cardiovascular disease in women: Insights from magnetic resonance imaging. J Cardiovasc Magn Reson 2020;22:71.
Baldassarre LA, Raman SV, Min JK, et al. American College of Cardiology's cardiovascular disease in women committee. Non-invasive imaging to evaluate women with stable ischemic heart disease. JACC Cardiovasc Imaging 2016;9:421-435.
Williams MC, Hunter A, Shah ASV, et al. Use of coronary computed tomographic angiography to guide management of patients with coronary disease. J Am Coll Cardiol 2016;67:1759-1768.